P. Navolanic

发表

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy

J. McCubrey, John T. Lee, L. Steelman, 2003, Leukemia.

EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).

J. McCubrey, L. Steelman, P. Navolanic, 2003, International journal of oncology.

Docetaxel Cytotoxicity is Enhanced by Inhibition of the Raf/MEK/ERK Signal Transduction Pathway

J. McCubrey, John T. Lee, P. Navolanic, 2003, Cancer biology & therapy.

Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia

J. McCubrey, M. McMahon, John T. Lee, 2003, Leukemia.

Analysis of BRAF Mutation in Primary and Metastatic Melanoma

J. McCubrey, F. Stivala, M. Libra, 2005, Cell cycle.

Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).

J. McCubrey, John T. Lee, L. Steelman, 2003, International journal of oncology.

Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease

R. Talamini, F. Stivala, M. Libra, 2006, Journal of Clinical Pathology.

Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease

K. Mangano, M. Libra, S. Signorelli, 2016, Angiology.

Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance.

M. Konopleva, J. McCubrey, L. Steelman, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors

Stephen L. Abrams, D. Terrian, J. McCubrey, 2008, Oncogene.

Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin.

J. McCubrey, M. McMahon, C. Henríquez-Roldán, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Neosis and its Potential Role in Cancer Development and Chemoresistance

J. McCubrey, S. M. Akula, P. Navolanic, 2004, Cancer biology & therapy.

Hepatitis C virus (HCV) infection and lymphoproliferative disorders

M. Libra, P. Navolanic, A. Carbone, 2005, Frontiers in bioscience : a journal and virtual library.

Elucidation of signal transduction pathways by retroviral infection of cells with modified oncogenes.

J. McCubrey, John T. Lee, L. Steelman, 2003, Methods in molecular biology.

Second Primary Lymphoma or Recurrence: A Dilemma Solved by VDJ Rearrangement Analysis

M. Libra, P. Navolanic, A. Carbone, 2004, Leukemia & lymphoma.

Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy

Giuseppe Toffoli, Massimo Libra, R. Talamini, 2004, BMC Cancer.

Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002

C. Pui, R. Larson, J. McCubrey, 2003, Leukemia.

Combining chemo-, hormonal and targeted therapies to treat breast cancer (Review).

J. McCubrey, F. Stivala, M. Libra, 2008, Molecular medicine reports.

Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.

Stephen L. Abrams, D. Terrian, J. McCubrey, 2008, Advances in enzyme regulation.

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

Stephen L. Abrams, F. E. Bertrand, D. Terrian, 2006, Advances in enzyme regulation.

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention

J. McCubrey, John T. Lee, L. Steelman, 2003, Leukemia.

A spindle cell variant of diffuse large B-cell lymphoma possesses genotypic and phenotypic markers characteristic of a germinal center B-cell origin

M. Libra, P. Navolanic, A. Carbone, 2006, Modern Pathology.

Chemotherapy for Breast Cancer

J. McCubrey, A. Martelli, L. Steelman, 2008 .

Fibroblastic, hematopoietic, and hormone responsive epithelial cell lines and culture conditions for elucidation of signal transduction and drug resistance pathways by gene transfer.

J. McCubrey, John T. Lee, L. Steelman, 2003, Methods in molecular biology.

Aggressive forms of non-Hodgkin's lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses.

F. Stivala, M. Libra, P. Navolanic, 2005, International journal of oncology.

Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease

Giuseppe Pennisi, Massimo Libra, M. Libra, 2005, Vascular medicine.

Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells

Stephen L. Abrams, Massimo Libra, Lucio Cocco, 2011, Cell cycle.

Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection.

M. Libra, P. Navolanic, A. Carbone, 2004, Haematologica.

Gene Usage among HCV-Associated 6 H J

M. Libra, P. Navolanic, A. Carbone, 2017 .

Lymphomas Harboring t(14;18) Translocation Gene Usage among HCV-Associated MALT 6 H J

M. Libra, P. Navolanic, A. Carbone, 2011 .

JH6 Gene Usage among HCV-Associated MALT Lymphomas Harboring t(14;18) Translocation

M. Libra, P. Navolanic, A. Carbone, 2005, The Journal of Immunology.

TranslocationMALT Lymphomas Harboring t(14;18) Gene Usage among HCV-Associated 6HJ

M. Libra, P. Navolanic, A. Carbone, 2005 .

Translocation MALT Lymphomas Harboring t ( 14 ; 18 ) Gene Usage among HCV-Associated 6 HJ

M. Libra, P. Navolanic, A. Carbone, 2005 .

Identification of Isoforms of a Mitotic Motor in Mammalian Spermatogenesis1

P. Navolanic, A. Sperry, 2000, Biology of reproduction.